Gabagesic Gel is a topical formulation combining Gabapentin (6% w/w), Lidocaine (5% w/w), and Baclofen (2% w/w) designed to provide effective relief from neuropathic pain, muscle spasms, and localized discomfort. Gabapentin, an anticonvulsant, modulates nerve activity to reduce neuropathic pain signals, while Lidocaine, a local anesthetic, provides rapid numbing and pain relief by blocking sodium channels in nerve membranes. Baclofen, a muscle relaxant, acts on GABA receptors to alleviate muscle spasticity and cramps. The gel formulation allows for targeted application, minimizing systemic side effects commonly associated with oral administration of these agents. Gabagesic Gel is particularly useful for patients experiencing chronic pain conditions such as postherpetic neuralgia, diabetic neuropathy, or musculoskeletal disorders where muscle stiffness and nerve pain coexist. It is applied directly to the affected area, promoting localized absorption and quick onset of action. Patients should use Gabagesic Gel as directed by a healthcare professional, avoiding broken skin and mucous membranes. Common side effects may include mild skin irritation or redness at the application site. This combination therapy offers a multi-modal approach to pain management, enhancing patient comfort and improving quality of life.